Time course of vascular structural changes during and after short-term antihypertensive treatment

Hypertension

Volumn 42, Issue 2, 2003, Pages 171-176

  Hale, Taben M ^b   Shoichet, Martin J ^b   Bushfield, Terri L ^b   Adams, Michael A ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b NONE

Author keywords

Antihypertensive agents; Arterial pressure; Hypertension, experimental; Rats, inbred SHR; Sodium, dietary; Vascular resistance

Indexed keywords

ANTIHYPERTENSIVE AGENT; ENALAPRIL; HYDRALAZINE; HYDROCHLOROTHIAZIDE; NIFEDIPINE; UROKINASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL DIAMETER; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HEART LEFT VENTRICLE MASS; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SHORT COURSE THERAPY; SODIUM RESTRICTION; TREATMENT OUTCOME; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATATION; ANIMAL; BLOOD PRESSURE; BLOOD VESSEL; DRUG COMBINATION; HEART LEFT VENTRICLE HYPERTROPHY; HINDLIMB; KINETICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULARIZATION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD VESSELS; DRUG THERAPY, COMBINATION; ENALAPRIL; HINDLIMB; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KINETICS; MALE; RATS; RATS, INBRED SHR; URINARY PLASMINOGEN ACTIVATOR; VASCULAR RESISTANCE;

EID: 0043268712     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000079309.68998.65     Document Type: Article

References (40)

1. Korner PI., Bobik A. Cardiovascular development after enalapril in spontaneously hypertensive and Wistar-Kyoto rats. Hypertension. 1995;25:610-619.
2. Lundie MJ, Friberg P, Kline RL, Adams MA. Long-term inhibition of the renin-angiotensin system in genetic hypertension: analysis of the impact on blood pressure and cardiovascalar structural changes. J Hypertens. 1997;15:339-348.
3. Hale TM, Okabe H, Bushfield TL, Heaton JP, Adams MA. Recovery of erectile function after brief aggressive antihypertensive therapy. J Urol. 2002;168:348-354.
4. Rizzoni D, Castellano M, Porteri E, Bettoni G, Muiesan ML, Cinelli A, Zulli R, Rosei EA. Prolonged effects of short-term fosinopril on blood pressure and vascular morphology and function in rats. Am J Hypertens. 1997:10:1034-1043.
5. Heller J, Hellerova S. Long-term effect on blood pressure of early brief treatment by different antihypertensive agents: a study in the Prague hypertensive rat. Kidney Blood Press Res. 1998;21:445-451.
6. Ledingham JM, Laverty R. Renal afferent arteriolar structure in the genetically hypertensive (GH) rat and the ability of losartan and enalapril to cause structural remodelling. J Hypertens. 1998;16:1945-1952.
7. Ledingham JM, Laverty R. Remodelling of resistance arteries in genetically hypertensive rats by treatment with valsartan, an angiotensin II receptor antagonist. Clin Exp Pharmacol Physiol. 1996;23:576-578.
8. Adams MA, Bobik A, Korner PI. Enalapril can prevent vascular amplifier development in spontaneously hypertensive rats. Hypertension. 1990;16:252-260.
9. Woolard J, Hale TM, Bushfield TL, Adams MA. Persistent lowering of arterial pressure after continuous and intertmittent therapy. J Hypertens. 2003;21:813-820.
10. Mulvany MJ, Persson AE, Andresen J. No persistent effect of angiotensin converting enzyme inhibitor treatment in Milan hypertensive rats despite regression of vascular structure. J. Hypertens. 1991;9:589-593.
11. Christensen HR, Nielsen H, Christensen KL, Baandrup U, Jespersen LT, Mulvany MJ. Long-term hypotensive effects of an angiotensin converting enzyme inhibitor in spontaneously hypertensive rats: is there a role for vascular structure? J Hyperten. 1988;6(suppl):S27-S31.
12. Morton JJ, Beattie EC, Macpherson F. Angiotensin II receptor antagonist losartan has persistent effects on blood pressure in the young spontaneously hypertensive rat: lack of relation to vascular structure. J Vase Res. 1992;29:264-269.
13. Gohlke P, Linz W, Scholkens B, Van Even Martorana P, Unger T. Vascular and cardiac protection by ramipril in spontaneously hypertensive rats: prevention versus regression study. Br J Clin Pract Suppl. 1996;84:1-10.
14. Paull JR, Widdop RE. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats. J Hypertens. 2001;19:1393-1402.
15. Baumbach GL, Chillon JM. Effects of angiotensin-converting enzyme inhibitors on cerebral vascular structure in chronic hypertension. J Hypertens. 2000;18(suppl):S7-S11.
16. Thybo NK, Korsgaard N, Eriksen S, Christensen KL, Mulvany MJ. Dose-dependent effects of perindopril on blood pressure and small-artery structure. Hypertension. 1994;23:659-666.
17. Porteri E, Rizzoni D, Piccoli A, Castellano M, Bettoni G, Muiesan ML, Pasini G, Guelfi D, Zulli R, Rosei EA. Effects of hypotensive and non-hypotensive doses of manidipine on structure, responses to endothelin-1 and ICAM-1 production in mesenteric small resistance arteries of spontaneously hypertensive rats. Blood Press. 1998;7:324-330.
18. Nielsen H, Christensen HR, Christensen KL, Baandrup U, Jespersen LT. Antitrophic properties of antihypertensive drugs may depend solely on their blood pressure-lowering capability. A comparative study of isradipine, hydralazine, and metoprolol. Am J Med. 1989;86:67-69.
19. Harrap SB, Van der Griffin SA, Macpherson F, Lever AF. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension. 1990;16:603-614.
20. Christensen KL, Jespersen LT, Mulvany MJ. Development of blood pressure in spontaneously hypertensive rats after withdrawal of long-term treatment related to vascular structure. J Hypertens. 1989;7:83-90.
21. Freslon JL, Giudicelli JF. Compared myocardial and vascular effects of captopril and dihydralazine during hypertension development in spontaneously hypertensive rats. Br J Pharmacol. 1983;80:533-543.
22. Rizzoni D, Castellano M, Porteri E, Bettoni G, Muiesan ML, Agabiti Rosei E. Delayed development of hypertension after short-term nitrendipine treatment. Hypertension. 1994;24:131-139.
23. Weiss L. Long-term treatment with antihypertensive drugs in spontaneously hypertensive rats (SHR). Effects on blood pressure, survival rate and cardiovascular design. Acta Physiol Scand. 1974;91:393-408.
24. Hale TM, Okabe H, Heaton JP, Adams MA. Antihypertensive drugs induce structural remodeling of the penile vasculature. J Urol. 2001;166:739-745.
25. Hof RP, Hof Miyashita A, Evenou JP. Hemodynamic effects of a new angiotensin converting enzyme inhibitor, spirapril, in sodium-loaded and sodium-depleted rabbits. J Cardiovasc Pharmacol. 1987;10:599-606.
26. Banting JD, Thompson KE, Friberg P, Adams MA. Blunted cardiovascular growth induction during prolonged nitric oxide synthase blockade. Hypertension. 1997;30:416-421.
27. Mulvany MJ, Hansen OK, Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res. 1978;43:854-864.
28. Korner PI, Angus JA. Structural determinants of vascular resistance properties in hypertension. Haemodynamic and model analysis. J Vasc Res. 29:293-312.
29. Graham CH, Forsdike J, Fitzgerald CJ, Macdonald Goodfellow S. Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. Int J Cancer. 1999;80:617-623.
30. deBlois D, Tea BS, Than VD, Tremblay J, Hamet P. Smooth muscle apoptosis during vascular regression in spontaneously hypertensive rats. Hypertension. 1997;29:340-349.
31. Sharifi AM, Schiffrin EL. Apoptosis in vasculature of spontaneously hypertensive rats: effect of an angiotensin converting enzyme inhibitor and a calcium channel antagonist. Am J Hypertens. 1998;11:1108-1116.
32. Otsuka S, Sugano M, Makino N, Sawada S, Hata T, Niho Y. Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats. Hypertension. 1998;32:467-472.
33. Rizzoni D, Porteri E, Piccoli A, Castellano M, Bettoni G, Muiesan ML, Pasini G, Guelfi D, Mulvany MJ, Agabiti Rosei EA. Effects of losartan and enalapril on small artery structure in hypertensive rats. Hypertension. 1998;32:305-310.
34. Sharifi AM, Li JS, Endemann D, Schiffrin EL. Effects of enalapril and amlodipine on small-artery structure and composition, and on endothelial dysfunction in spontaneously hypertensive rats. J Hypertens. 1998;16:457-466.
35. Parfyonova YV. Plekhanova OS, Tkachuk VA. Plasminogen activators in vascular remodeling and angiogenesis. Biochemistry (Mosc). 2002;67:119-134.
36. Levi M, Moons L, Bouche A, Shapiro SD, Collen D, Carmeliet P. Deficiency of urokinase-type plasminogen activator-mediated plasmin generation impairs vascular remodeling during hypoxia-induced pulmonary hypertension in mice. Circulation. 2001;103:2014-2020.
37. Buus CL, Pourageaud F, Fazzi GE, Janssen G, Mulvany MJ, De Mey JG. Smooth muscle cell changes during flow-related remodeling of rat mesenteric resistance arteries. Circ Res. 2001;89:180-186.
38. Unthank JL, Fath SW, Burkhart HM, Miller SC, Dalsing MC. Wall remodeling during luminal expansion of mesenteric arterial collaterals in the rat. Circ Res. 1996;79:1015-1023.
39. Unthank JL, Nixon JC, Burkhart HM, Fath SW, Dalsing MC. Early collateral and microvascular adaptations to intestinal artery occlusion in rat. Am J Physiol. 1996;271:H914-H923.
40. Julius S. Of rat and man. J Hypertens. 2003;21:705-706.